CIBC Private Wealth Group
LENZ

CIBC Private Wealth Group’s LENZ Therapeutics LENZ Stock Holding History

CIBC Private Wealth Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$18.3K Hold
1,146
– – ﹤0.01% 2193
2025
Q3 		$53.4K Hold
1,146
– – ﹤0.01% 1761
2025
Q2 		$33.6K Hold
1,146
– – ﹤0.01% 1819
2025
Q1 		$21K Hold
1,146
– – ﹤0.01% 1971
2024
Q4 		$30.2K Hold
1,146
– – ﹤0.01% 1894
2024
Q3 		$27.2K Buy
+1,146
New +$25.4K ﹤0.01% 2027

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

CIBC Private Wealth Group's LENZ Position: Q4 2025 in Review

CIBC Private Wealth Group held its LENZ Therapeutics (LENZ) position steady in Q4 2025 at 1,146 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

CIBC Private Wealth Group first reported a position in LENZ in Q3 2024 and has held it in 6 quarters since. The position peaked at $53.4K in Q3 2025. 160 funds tracked by Wall St. Rank hold LENZ as of Q4 2025.

  • CIBC Private Wealth Group held 1,146 shares of LENZ Therapeutics worth $18.3K as of Q4 2025.
  • CIBC Private Wealth Group left its LENZ Therapeutics share count unchanged in Q4 2025.
  • LENZ Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2193 holding.
  • CIBC Private Wealth Group first reported a position in LENZ Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • CIBC Private Wealth Group's LENZ Therapeutics position peaked at $53.4K in Q3 2025.
  • 160 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.